Mycophenolat Mofetil Sandoz (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycophenolat Mofetil Sandoz, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat lupus nephritis in appropriate patients.

GNH USA supplies Mycophenolat Mofetil Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil acts on the immune system to reduce lymphocyte proliferation, making it useful in several transplant and autoimmune settings. - Kidney transplant rejection: helps prevent acute and chronic rejection episodes. - Heart transplant rejection: reduces the risk of graft failure. - Liver transplant rejection: supports long‑term graft survival. - Lupus nephritis: diminishes renal inflammation and proteinuria.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools. - Vomiting: occasional emesis. - Abdominal pain: cramping or discomfort. - Headache: transient cephalgia. - Upper respiratory infection: mild viral symptoms.

Serious or Rare Side Effects: - Leukopenia: significant reduction in white blood cells. - Anemia: decreased red blood cell count. - Severe infections: opportunistic or bacterial infections. - Malignancy: increased risk of certain cancers. - Hepatic dysfunction: elevated liver enzymes. - Progressive multifocal leukoencephalopathy: rare viral brain infection.

Before initiating therapy, clinicians should assess baseline labs and patient risk factors. - Monitor blood counts: regular CBC to detect leukopenia or anemia. - Monitor renal function: assess serum creatinine and eGFR. - Monitor liver enzymes: check ALT/AST periodically. - Avoid live vaccines: risk of uncontrolled infection. - Counsel on infection risk: advise prompt reporting of fever or signs of infection. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Mycophenolate Mofetil can interact with several drugs, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of mycophenolic acid. - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increases mycophenolate exposure, raising toxicity risk. - Rifampin: induces metabolism, decreasing drug levels. - Live vaccines: may cause severe infection.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may exacerbate renal impairment. - NSAIDs: increase risk of renal dysfunction when combined. - Warfarin: may alter INR, requiring closer monitoring.